Harvard Bioscience Inc.
HBIO | NASDAQ
$8.90
+$0.10 (+1.14%)
At close: Oct 30, 2026, 4:00 PM ET
$8.90
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -10.41M | -9.78M | -56.7M | -53.84M | -57.41M | -58.05M | -12.41M | -14.24M | -10.68M | -8.73M | -3.42M | -3.26M | -5.43M | -2.01M | -9.52M | -6.89M | -3.65M | -6.5M | -288K | -1.86M | -2.79M | -3.96M |
Depreciation & Amortization | 5.4M | 5.64M | 5.95M | 6.36M | 6.85M | 7.03M | 7.23M | 7.24M | 7.2M | 7.12M | 6.99M | 7.18M | 7.34M | 7.45M | 7.58M | 7.54M | 7.48M | 7.56M | 7.62M | 8.51M | 8.47M | 8.61M |
Stock-Based Compensation | 1.04M | 1.51M | 1.86M | 2.36M | 3.09M | 3.89M | 4.34M | 4.76M | 5.07M | 4.9M | 5M | 3.62M | 3.39M | 3.53M | 3.4M | 4.43M | 4.3M | 4.22M | 4.17M | 4.14M | 4.22M | 3.82M |
Other Working Capital | 2.19M | 1.18M | 1.36M | 668K | 2.34M | 1.72M | 940K | 2.17M | 559K | -1.41M | -495K | -1.34M | -2.29M | -3.16M | -1.35M | -1.29M | -1.2M | 3.01M | -35K | -957K | -1.45M | -1.28M |
Other Non-Cash Items | 3.67M | 3M | 50.64M | 47.5M | 48.48M | 48.62M | 1.85M | 3.33M | 858K | 3.52M | 1.88M | 2.79M | 3.99M | -2.85M | -2.45M | -3.62M | -3.62M | 280K | 280K | 1.86M | 4.42M | 4.1M |
Deferred Income Tax | -199K | -242K | -680K | 171K | -617K | -338K | 363K | -117K | 657K | 569K | 336K | -322K | -1.53M | -506K | -574K | 8K | 1.01M | -400K | -330K | -498K | -3.23M | -2.98M |
Change in Working Capital | 1.16M | 2.96M | 5.67M | 6M | 6.24M | 1.87M | 65K | 3.05M | 6.11M | 6.24M | 3.24M | 2.4M | 923K | -656K | 2.72M | -2.88M | -8.24M | -6.93M | -10.19M | -8.51M | -5.2M | -2.1M |
Operating Cash Flow | 649K | 3.08M | 6.73M | 8.55M | 6.62M | 3.02M | 1.44M | 4.02M | 9.22M | 13.62M | 14.03M | 12.4M | 8.69M | 4.95M | 1.15M | -1.41M | -2.72M | -1.76M | 1.26M | 3.64M | 5.89M | 7.5M |
Capital Expenditures | -2.06M | -1.61M | -1.86M | -1.73M | -2.26M | -2.85M | -2.88M | -3.48M | -3M | -2.7M | -2.2M | -1.38M | -1.42M | -1.34M | -1.59M | -1.71M | -1.75M | -1.52M | -1.35M | -1.05M | -1.14M | -1.21M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -512K | -512K | -512K | n/a | 512K | 512K | 512K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 1.42M | 1.92M | 1.92M | 1.92M | 495K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -485K | -629K | -605K | -620K | -710K | -714K | -544K | 133K | 364K | 404K | 404K | -108K | -108K | n/a | n/a | n/a | n/a | n/a | -150K | -400K | -400K | -400K |
Investing Cash Flow | -2.48M | -1.8M | -1.86M | -1.73M | -2.49M | -1.8M | -1.34M | -1.94M | -1.23M | -2.31M | -1.8M | -973K | -1.01M | -831K | -1.59M | -1.71M | -1.75M | -1.52M | -1.35M | -1.3M | -1.39M | -1.46M |
Debt Repayment | 4.65M | 3.65M | 2.65M | -4M | -750K | 250K | 227K | -1.02M | -6.02M | -8.72M | -10.54M | -10.79M | -7.34M | -5.19M | -1.79M | 3.76M | 5.06M | 5.11M | 50K | 2.04M | -301K | -11.38M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -260K | -880K | -900K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -481K | -481K | -481K | -481K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -3.68M | -3.94M | -3.99M | -1.14M | -1.03M | -734K | -577K | -1.81M | -1.65M | -1.93M | -2.04M | -912K | -1.3M | -1.03M | -1.35M | -1.34M | -2.47M | -2.13M | -302K | -1.27M | 252K | 6.25M |
Financial Cash Flow | 1.13M | -96K | -1.29M | -5.1M | -1.72M | -280K | -131K | -2.89M | -7.74M | -10.3M | -12.13M | -10.75M | -7.62M | -5.82M | -2.84M | 2.49M | 2.6M | 2.98M | -252K | 511K | -929K | -6.04M |
Net Cash Flow | -939K | 1.55M | 4.51M | 2.25M | 3.39M | 1.29M | -175K | -771K | -293K | 449K | -242K | 179K | 65K | -1.64M | -3.31M | -404K | -1.98M | -382K | -496K | 2.74M | 3.61M | -67K |
Free Cash Flow | -1.41M | 1.48M | 4.87M | 6.82M | 4.36M | 176K | -1.44M | 539K | 6.22M | 10.92M | 11.83M | 11.03M | 7.27M | 3.61M | -438K | -3.12M | -4.47M | -3.28M | -83K | 2.58M | 4.76M | 6.29M |
Adj. Free Cash Flow | -2.45M | -37K | 3.01M | 4.46M | 1.28M | -3.72M | -5.78M | -4.22M | 1.15M | 6.03M | 6.83M | 7.41M | 3.88M | 76K | -3.84M | -7.56M | -8.77M | -7.5M | -4.25M | -1.56M | 540K | 2.46M |
Maintenance CapEx | -2.06M | -1.61M | -1.86M | -1.73M | -2.26M | -2.85M | -2.88M | -3.48M | -3M | -2.7M | -2.11M | -1.28M | -1.32M | -1.25M | -1.45M | -1.43M | -1.06M | -621.05K | -355.19K | -209.12K | -697.12K | -980.12K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -96.38K | -96.38K | -96.38K | -97.21K | -136.06K | -284.78K | -688.78K | -893.95K | -989.81K | -841.88K | -437.88K | -231.88K |
Owner Earnings | -1.41M | 1.48M | 4.87M | 6.82M | 4.36M | 176K | -1.44M | 539K | 6.22M | 10.92M | 11.92M | 11.12M | 7.37M | 3.7M | -301.94K | -2.84M | -3.78M | -2.38M | 906.81K | 3.43M | 5.19M | 6.52M |
Add to Watchlist
Select watchlists to add or remove HBIO